Newsletter | July 29, 2020

07.29.20 -- Is Puerto Rico The Answer To U.S. Pharma Manufacturing?

Ask The Board
What Are Strategies Biopharmas Can Use To Educate And Influence Change Within Their Organization?

See the answer from Chhaya Shah, SVP of tech ops at Radius Health.

Will The “Work From Home” Concept Ever Take Off In The Biopharma Industry? If Yes, What Conditions/Trends Will Enable It To Happen? If Not, What Are The Barriers Stopping The Industry From Embracing This Trend?

See the answer from Leslie Williams, the former president, CEO, and founder of ImmusanT.

How Can A Cell Therapy Manufacturer Avoid The Impact Of Supply Chain Disruptions Via Single-Use Systems (SUS), While Also Being Sustainable For The Environment?

See the answer from Raúl Diaz, who directs MSD Animal Health Large Molecules Biopharm Operations in Montes Claros, Brazil.

Web-Exclusive Articles
Remote Monitoring In The Wake Of COVID-19: Practical And Regulatory Considerations

In the long term, as we move into the reopening phases of COVID-19, faced with increased expenses and the challenges with on-site monitoring, clinical research professionals need to ensure their quality management systems have the flexibility for the new normal for site management.

Is Puerto Rico The Answer To U.S. Pharma Manufacturing?

In episode 17 of the Life Science Connect podcast, Outsourced Pharma Chief Editor Louis Garguilo elaborates on his recent editorial regarding the immense opportunity that Puerto Rico offers — and has offered for years — pharma manufacturers looking to bring back operations to the states.

July 2020 Digital Edition

Inside you will find more on:

  • Outsourcing Research
  • Antibiotic Research
  • CEO Corner
  • Regulatory Info

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.